Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› East Melbourne
Clinical trial register · Australia

Clinical Trials in East Melbourne, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca13 Pfizer7 Hoffmann-La Roche6 Janssen Research & Development, LLC5 AbbVie5
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in East Melbourne

116 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
A Study of KMV002 in Patients With mAPMR Prostate Cancer
NCT07866300Prostate Cancer Metastatic Castration-Resistant
Chimivac INC
Phase 1
24
North Ryde, East Melbourne
2026-11
Recruiting
Biojiva LLC
Phase 1/2
152
Albury, Baulkham Hills, Hurstville, Sydney, East Melbourne, Rowville
2026-09-29
Recruiting
Serum Institute of India Pvt. Ltd.
Phase 1
36
East Melbourne
2026-09-11
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
Sydney, Westmead, South Brisbane, Adelaide, East Melbourne, Parkville
2026-09-11
Not yet open
First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)
NCT07766473Neovascular (Wet) Age-Related Macular Degeneration
Filamon LTD
Phase 1/2
24
Gosford, Sydney, Westmead, East Melbourne
2026-09
Recruiting
AbbVie
Phase 3
300
East Melbourne
2026-08-24
Recruiting
AstraZeneca
Phase 1/2
101
Camperdown, East Melbourne
2026-07-27
Recruiting
AstraZeneca
Phase 3
750
Concord, Darlinghurst, East Melbourne, Fitzroy, Liverpool, Melbourne, Murdoch, Waratah
2026-06-26
Recruiting
Yarrow Bioscience, Inc.
Phase 2
232
East Melbourne, Melbourne N.
2026-06-10
Recruiting
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
NCT07623525Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
Diagonal Therapeutics, Inc.
Phase 1/2
93
Camperdown, Randwick, Herston, East Melbourne, Parkville, West Perth
2026-06-04
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-22
Recruiting
Kite, A Gilead Company
Phase 3
550
Camperdown, Sydney, East Melbourne
2026-05-22
Recruiting
Incyte Corporation
Phase 1
218
Concord, St Leonards, Auchenflower, East Melbourne, Nedlands
2026-05-11
Recruiting
Aquarius Pilot Study to Evaluate the New Axonics Trial System
NCT07335484Urinary Urge Incontinence (UUI), Urinary Frequency (UF), Fecal Incontinence (FI), Overactive Bladder (OAB)
Axonics, Inc.
Not applicable
75
North Adelaide, East Melbourne
2026-04-30
Active, closed
Contralateral Claims Study of Clareon Vivity Pro
NCT07484191Aphakia, Presbyopia
Alcon Research
Not applicable
165
Campsie, Sydney, Wollongong, Woolloongabba, East Melbourne, Mornington
2026-04-28
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsCetuximab·Nab-paclitaxel·Gemcitabine
Revolution Medicines, Inc.
Phase 3
900
Kogarah, Randwick, Waratah, Herston, East Melbourne, Heidelberg
2026-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
272
Albury, Parramatta, Strathfield, East Melbourne
2026-03-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Westmead, Brisbane, East Melbourne
2026-02-16
Recruiting
Arrowhead Pharmaceuticals
Phase 1/2
78
Charlestown, Morayfield, East Melbourne, Melbourne, Perth, Clayton
2025-12-22
Recruiting
Olix Pharmaceuticals, Inc.
Phase 1/2
158
Botany, Kogarah, Newcastle, Camberwell, East Melbourne, Mitcham
2025-12-04
Active, closed
Cochlear
Not applicable
36
Camperdown, Macquarie, Westmead, East Melbourne
2025-12-01
Recruiting
Amgen
Phase 3
750
Waratah, Auchenflower, Southport, Clayton, East Melbourne
2025-11-28
Recruiting
Neurotech Pharmaceuticals
Phase 4
234
East Melbourne, Perth, Sydney
2025-11-21
Recruiting
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
NCT07421739Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma
Aura Biosciences
Observational
15
East Melbourne
2025-11-12
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Albury, Hurstville, Parramatta, Sutherland, Sydney, East Melbourne, Rowville, Malvern
2025-11-10
Recruiting
Sanofi
Phase 1/2
104
Sydney, Adelaide, East Melbourne
2025-10-09
Recruiting
Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)
NCT06970106OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies, Kjer Optic Atrophy
DrugPYC-001
PYC Therapeutics
Phase 1/2
24
Sydney, East Melbourne
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Darlinghurst, Kogarah, Westmead, Greenslopes, Woolloongabba, Carlton, Clayton, East Melbourne
2025-09-22
Recruiting
Center for Eye Research Australia
Phase 4
144
East Melbourne, Geelong
2025-09-19
Not yet open
LTFU for All Cell and Gene Therapy Studies
NCT06194461Hepatocellular Carcinoma, Prostate Cancer
DrugsAZD0754·AZD5851
AstraZeneca
Observational
64
East Melbourne
2025-09-17
Recruiting
Kiora Pharmaceuticals, Inc.
Phase 2
36
Sydney, Woolloongabba, Adelaide, East Melbourne, Nedlands
2025-08-29
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT07115043Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma
DrugRilvegostomig
AstraZeneca
Phase 1/2
120
East Melbourne
2025-07-29
Active, closed
Apogee Therapeutics, Inc.
Phase 1
86
Darlinghurst, Kogarah, Westmead, Woolloongabba, Carlton, East Melbourne, Mitcham, Parkville
2025-06-04
Recruiting
Design Therapeutics, Inc.
Phase 1/2
20
Sydney, East Melbourne, Melbourne
2025-06
Active, closed
An Investigation to Evaluate Sound Coding Enhancements in Adult Cochlear Implant Recipients
NCT06867380Cochlear Implant Recipients, Hearing Loss, Cochlear
Cochlear
Not applicable
120
Carlton, East Melbourne
2025-05-27
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
Not applicable
100
East Melbourne
2025-05-07
Recruiting
Kiora Pharmaceuticals, Inc.
Phase 2
28
Sydney, Westmead, Adelaide, Hobart, East Melbourne, Nedlands
2025-05-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Sydney, Brisbane, East Melbourne, Frankston
2025-04-09
Recruiting
AstraZeneca
Phase 3
600
Blacktown, East Melbourne, Nedlands, South Brisbane
2025-03-27
Active, closed
Hoffmann-La Roche
Phase 4
274
Strathfield, Sydney, Adelaide, East Melbourne, Rowville, Nedlands
2025-03-14
Recruiting
AstraZeneca
Phase 2
80
East Melbourne, Wollongong, Woodville South
2025-03-12
Recruiting
AstraZeneca
Phase 1
136
East Melbourne
2025-03-10
Recruiting
Hoffmann-La Roche
Phase 2
130
East Melbourne
2025-03-05
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Kogarah, Campbelltown, Carlton, East Melbourne
2025-01-08
Active, closed
SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)
NCT06461286OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies, Kjer Optic Atrophy
DrugPYC-001
PYC Therapeutics
Phase 1
18
Sydney, East Melbourne
2024-10-31
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Albury, Hurstville, Strathfield, Adelaide, East Melbourne
2024-10-30
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
East Melbourne, Strathfield, Sydney, Westmead
2024-09-19
Recruiting
Acute Retinal Detachment Repair With the iSeelr™ Retinal Detachment Repair System
NCT06468397Rhegmatogenous Retinal Detachment - Macula Off
Photofuse Pty Ltd
Not applicable
10
East Melbourne
2024-09-13
Active, closed
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Priovant Therapeutics, Inc.
Phase 3
371
Sydney, East Melbourne, Nedlands
2024-09-11
Recruiting
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
NCT06393738Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL), Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)
DrugGlofitamab
Arvinas Inc.
Phase 1
329
East Melbourne
2024-09-05
Active, closed
Amgen
Phase 3
89
Sydney, Wooloongabba, Adelaie, East Melbourne
2024-07-05
Active, closed
AbbVie
Phase 3
1,400
Phillip, Darlinghurst, Kogarah, Woolloongabba, East Melbourne
2024-06-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Westmead, Brisbane, East Melbourne, Frankston, Nedlands
2024-06-20
Active, closed
Beacon Therapeutics
Phase 2/3
85
Sydney, East Melbourne
2024-03-14
Recruiting
Ontario Clinical Oncology Group (OCOG)
Observational
352
Cudgen, Liverpool, North Sydney, Westmead, Herston, Woolloongabba, Bentleigh East, East Melbourne
2024-03-12
Recruiting
AstraZeneca
Phase 1/2
60
East Melbourne
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,400
Gateshead, Tiwi, Clayton, East Melbourne
2024-02-28
Active, closed
Pfizer
Phase 1
100
Liverpool, Waratah, Douglas, East Melbourne, Richmond
2024-02-20
Active, closed
Pfizer
Phase 3
394
Darlinghurst, Campbelltown, Carlton, East Melbourne, Melbourne
2024-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Campbelltown, Canberra, East Melbourne, Greenslopes, Melbourne
2024-01-17
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Albury, Liverpool, Parramatta, Strathfield, Sydney, Adelaide, Hobart, East Melbourne
2024-01-09
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Liverpool, Waratah, Benowa, Hobart, East Melbourne
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Liverpool, Waratah, Auchenflower, Benowa, East Melbourne
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Liverpool, Auchenflower, Bedford Park, Clayton, East Melbourne, Melbourne
2023-12-12
Active, closed
VividWhite Pty Ltd
Not applicable
65
Sydney, Bedford Park, Doncaster East, East Melbourne, Fitzroy, Vermont South
2023-12-12
Active, closed
Aura Biosciences
Phase 3
108
East Melbourne
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
St Leonards, Sydney, Brisbane, East Melbourne, Frankston
2023-12-06
Recruiting
AstraZeneca
Phase 1/2
564
East Melbourne
2023-12-05
Active, closed
Nektar Therapeutics
Phase 2
396
Darlinghurst, Kogarah, Westmead, Woolloongabba, Campbelltown, East Melbourne, Melbourne
2023-11-15
Active, closed
AstraZeneca
Phase 3
1,902
East Melbourne
2023-11-14
Active, closed
Pfizer
Phase 3
1,571
Phillip, Kogarah, St Leonards, Woolloongabba, Campbelltown, Woodville South, East Melbourne, Melbourne
2023-11-08
Active, closed
Janssen Research & Development, LLC
Phase 3
684
East Melbourne, Greenslopes, Melbourne, Miranda, Mitcham, Parkville
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Darlinghurst, Kogarah, Coorparoo, Woolloongabba, Carlton, East Melbourne, Parkville, Fremantle
2023-10-11
Recruiting
Pfizer
Phase 2
340
Sydney, Box Hill, East Melbourne, Fremantle
2023-08-22
Active, closed
Belite Bio, Inc
Phase 3
429
Chatswood, Strathfield, Brisbane, Adelaide, East Melbourne, Crawley
2023-07-27
Active, closed
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
NCT06087458Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular AMD, Non-neovascular Age-related Macular Degeneration
DrugVOY-101
Perceive Biotherapeutics, Inc.
Phase 1/2
60
Sydney, East Melbourne
2023-06-21
Active, closed
AbbVie
Phase 3
1,328
Phillip, Darlinghurst, Carlton, East Melbourne, Melbourne
2023-06-21
Recruiting
Jaeb Center for Health Research
Observational
1,500
East Melbourne
2023-05-11
Recruiting
The Bionics Institute of Australia
Not applicable
40
East Melbourne, Fitzroy, Geelong, Moonee Ponds, Parkville
2023-05-02
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation
DrugsPanitumumab·Folfox·Cetuximab·Nab-paclitaxel
Institut de Recherches Internationales Servier
Phase 1/2
554
East Melbourne, Westmead
2023-04-18
Active, closed
Bayer
Phase 3
985
Camperdown, Epping, Liverpool, Wahroonga, Adelaide, Box Hill, East Melbourne, Geelong
2023-04-03
Active, closed
Bristol-Myers Squibb
Phase 3
606
Camperdown, Gosford, Port Macquarie, St Leonards, Sydney, Adelaide, Bendigo, East Melbourne
2023-01-10
Active, closed
Novartis Pharmaceuticals
Phase 3
696
East Melbourne, Parkville
2022-12-09
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Hurstville, Westmead, Geebung, East Melbourne, Melbourne, Rowville, Broome, Nedlands
2022-11-21
Active, closed
AstraZeneca
Phase 2
194
Darlinghurst, East Melbourne, Herston, Woolloongabba
2022-08-11
Active, closed
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
NCT05573984Retinitis Pigmentosa, Eye Diseases, Hereditary, Retinal Dystrophies, Retinal Dystrophy Rod
PYC Therapeutics
Observational
50
Nedlands, East Melbourne
2022-07-07
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
East Melbourne, Albury, Sydney, Bendigo, St Albans
2022-06-30
Active, closed
Celgene
Phase 3
939
Birtinya, Douglas, Adelaide, Bedford Park, Clayton, East Melbourne, Melbourne, Murdoch
2022-06-23
Active, closed
AstraZeneca
Phase 1/2
174
Camperdown, Darlinghurst, East Melbourne, Heidelberg, Melbourne, St Leonards
2022-06-02
Active, closed
Genentech, Inc.
Observational
400
Parramatta, Sydney, Adelaide, East Melbourne, Nedlands
2022-05-27
Active, closed
Eli Lilly and Company
Phase 1
260
Adelaide, East Melbourne, Sydney
2022-05-11
Active, closed
Pfizer
Phase 3
854
Camperdown, Nowra, Westmead, Wollongong, Benowa, Clayfield, Woolloongabba, East Melbourne
2022-03-25
Recruiting
Hoffmann-La Roche
Phase 1
332
Woolloongabba, East Melbourne, Melbourne
2022-03-07
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Chermside, South Brisbane, Adelaide, Toorak Gardens, East Melbourne, Nedlands, Subiaco
2022-02-17
Active, closed
AstraZeneca
Phase 3
1,051
Box Hill, East Melbourne, Elizabeth Vale, Gosford, Heidelberg, Kogarah, South Brisbane, St Albans
2022-02-07
Active, closed
Amgen
Phase 1/2
329
Camperdown, East Melbourne, Parkville
2022-02-01
Active, closed
AbbVie
Observational
873
Miranda, Woolloongabba, Bedford Park, East Melbourne, Victoria Park, Newtown
2021-11-17
Recruiting
Kite, A Gilead Company
Phase 1/2
247
St Leonards, Sydney, Adelaide, Clayton, East Melbourne, Fitzroy
2021-10-27
Recruiting
Pfizer
Phase 3
893
Benowa, Clayfield, Greenslopes, Woolloongabba, East Melbourne, Fitzroy, Geelong, Melbourne
2021-10-04
Active, closed
Hoffmann-La Roche
Phase 3
451
Albury, Hurstville, Liverpool, Miranda, Sydney, Woolloongabba, East Melbourne, Rowville
2021-07-14
Active, closed
Pfizer
Phase 3
599
Camperdown, Wollongong, Brisbane, Southport, Woodville South, East Melbourne, Malvern, Richmond
2021-05-12
Active, closed
Hoffmann-La Roche
Observational
800
Camperdown, Liverpool, St Leonards, Bedford Park, East Melbourne
2021-05-10
Active, closed
Columbia University
Observational
122
Adelaide, Chatswood, East Melbourne, Maribyrnong, North Adelaide, Subiaco, Sydney
2021-05-06
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Blacktown, Wollongong, East Melbourne, Heidelberg, Nedlands, West Perth
2021-03-22
Recruiting
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
NCT04739319Age Related Macular Degeneration, Geographic Atrophy, AMD, Age-related Macular Degeneration
Center for Eye Research Australia
Observational
2,500
East Melbourne
2021-02-02
Active, closed
Canadian Cancer Trials Group
Phase 3
250
Bowral, Gateshead, Gosford, Macquarie University, Nowra, Birtinya, Toowoomba, East Melbourne
2021-01-27
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bundaberg, East Melbourne, Fitzroy, Hurstville, North Ryde, Waratah, Wembley
2020-11-12
Active, closed
Galderma R&D
Phase 3
1,700
Darlinghurst, Kogarah, Westmead, Benowa, Brisbane, Woodville, Carlton, East Melbourne
2019-12-30
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
East Albury, Tweed Heads, East Melbourne, Frankston, Geelong, Heidelberg, Perth
2019-11-13
Recruiting
Melanoma Institute Australia
Phase 2
218
Sydney, Waratah, Wollstonecraft, Woolloongabba, Adelaide, East Melbourne, Melbourne, Perth
2019-08-14
Active, closed
OBI Pharma, Inc
Phase 3
575
Westmead, Urraween, East Melbourne, Malvern, Nedlands, Darlinghurst, Gosford, Murdoch
2018-12-05
Active, closed
Yale University
Phase 2
190
East Melbourne
2018-03-20
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Camperdown, Adelaide, Melbourne, East Melbourne
2017-03-07
Active, closed
Melanoma Institute Australia
Phase 2
76
Wollstonecraft, Woolloongabba, Adelaide, East Melbourne
2014-11-04
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Darlinghurst, Liverpool, Waratah, South Brisbane, Adelaide, Kurralta Park, Clayton, East Melbourne
2014-11
Rows per page Showing 1–116 of 116
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/east-melbourne

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 116 of those studies with a site in East Melbourne.

How many clinical trials are recruiting in East Melbourne?

60 of the 116 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 53 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (East Melbourne), 116 studies
PhaseStudiesRecruitingShare
Phase 3441837.9%
Phase 1/2201517.2%
Phase 2181115.5%
Observational1149.5%
Phase 11058.6%
Not applicable846.9%
Phase 4322.6%
Phase 2/3211.7%

Most active sponsors

Lead sponsors with the most studies (East Melbourne)
Lead sponsorStudiesRecruiting
AstraZeneca138
Pfizer72
Hoffmann-La Roche62
AbbVie52
Janssen Research & Development, LLC53
Regeneron Pharmaceuticals54
Merck Sharp & Dohme LLC43
Amgen31
Bristol-Myers Squibb31
Novartis Pharmaceuticals32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.